By Angela McDaniels
Tacoma, Wash., Dec. 21 – Credit Suisse AG, London Branch priced $2.63 million of contingent coupon autocallable yield notes due Dec. 23, 2019 linked to the SPDR S&P Biotech exchange-traded fund and the Financial Select Sector SPDR fund, according to a 424B2 filing with the Securities and Exchange Commission.
Each quarter, the notes will pay a contingent coupon at the rate of 11% per year unless either fund closes below its barrier level, 60% of its initial share price, on the observation date for that quarter.
The notes will be automatically called at par if each fund closes at or above its initial share price on any quarterly observation date.
The payout at maturity will be par unless either fund finishes below its barrier level, in which case investors will be fully exposed to the decline of the lesser-performing fund.
Credit Suisse Securities (USA) LLC is the agent.
Issuer: | Credit Suisse AG, London Branch
|
Issue: | Contingent coupon autocallable yield notes
|
Underlying funds: | SPDR S&P Biotech ETF and Financial Select Sector SPDR fund
|
Amount: | $2,627,000
|
Maturity: | Dec. 23, 2019
|
Coupon: | Each quarter, notes pay contingent coupon at rate of 11% per year unless either fund closes below barrier level on observation date for that quarter
|
Price: | Par
|
Payout at maturity: | Par unless either fund finishes below barrier level, in which case full exposure to decline of lesser-performing fund
|
Call: | Automatically at par if each fund closes at or above initial share price on any quarterly observation date
|
Initial share prices: | $61.95 for biotech fund and $23.36 for financial fund
|
Barrier levels: | $37.17 for biotech fund and $14.016 for financial fund; 60% of initial share prices
|
Pricing date: | Dec. 16
|
Settlement date: | Dec. 21
|
Agent: | Credit Suisse Securities (USA) LLC
|
Fees: | 2.75%
|
Cusip: | 22548QQ57
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.